Video

Chief Endpoints and Potential Significance: Phase 3b OLIKOS Trial

Author(s):

Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC,Robert Naismith, MD

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Subscribe Now!
Related Videos
María L. De León, MD
Elizabeth Seng, PhD
Amaal Starling, MD, FAHS, FAAN
Molly Abbott, BM BCh
Laren Becker, MD, PhD
Related Content
Alon Ben-Noon, MBA (Credit: NeuroSense Therapeutics)
July 14th 2025

Late-Breaking Phase 2b PARADIGM Data Support Continued Development of PrimeC in ALS

Isabella Ciccone, MPH
Episode 145: Rewiring Stroke Recovery: What the Glymphatic System Can Teach Us
July 11th 2025

Episode 145: Rewiring Stroke Recovery: What the Glymphatic System Can Teach Us

Marco Meglio Joyce Lee-Iannotti, MD, FAAN, FAASM
30-Year Analysis Suggests Regression of Progressive Multiple Sclerosis, In Part to Advances in Therapeutics
July 12th 2025

30-Year Analysis Suggests Regression of Progressive Multiple Sclerosis, In Part to Advances in Therapeutics

Marco Meglio
Episode 142: World MS Day: Raising Awareness, Evolving Care, and Empowering Patients
May 30th 2025

Episode 142: World MS Day: Raising Awareness, Evolving Care, and Empowering Patients

Marco Meglio Taylor Hess, MD
NeuroVoices: Kumar Budur, MD, MS, on BP1.15205 as a Next-Gen Therapy for Narcolepsy
July 9th 2025

NeuroVoices: Kumar Budur, MD, MS, on BP1.15205 as a Next-Gen Therapy for Narcolepsy

Marco Meglio
SUNRISE Trial Confirms Effectiveness of Eptinezumab in Asian Population With Chronic Migraine
July 8th 2025

SUNRISE Trial Confirms Effectiveness of Eptinezumab in Asian Population With Chronic Migraine

Marco Meglio
© 2025 MJH Life Sciences

All rights reserved.